Health and Human Services News and Research

RSS

FDA approves new antiviral flu treatment

Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

24 Oct 2018

Federal court orders Tennessee-based company to stop selling OTC drug products

A federal court ordered a Tennessee-based company to stop selling over-the-counter (OTC) drug products until the company complies with the Federal Food, Drug, and Cosmetic Act and other requirements listed in a consent decree.

24 Oct 2018

Cocaine overdoses on the rise with fentanyl combo flooding the market

According to the figures from Centre for Disease Prevention and Control (CDC) there has been a sharp up-rise in the cocaine overdose over the last two years. The Drug Enforcement Administration (DEA) has also said there has been an inflow of Columbian cocaine into the United States.

24 Oct 2018

FDA targets 465 websites that sell potentially dangerous, unapproved drugs

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, acted this week to target 465 websites that illegally sell potentially dangerous, unapproved versions of opioid, oncology and antiviral prescription drugs to U.S. consumers.

23 Oct 2018

Researchers identify common genetic connection in lung conditions

An international research team led by members of the University of Colorado School of Medicine faculty has identified a genetic connection between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis.

22 Oct 2018

LU-RRTC to spearhead capacity-building efforts for racial and ethnic populations

Kessler Foundation scientists Denise Fyffe, PhD, Anthony Lequerica, PhD, and John O’Neill, PhD, have won a $75,000 sub-award from Langston University, a historically Black college/university.

19 Oct 2018

Podcast: KHN’s ‘What the Health?’ Republicans’ preexisting political problem

Ensuring that people with preexisting health conditions can get and keep health insurance has become one of the leading issues around the country ahead of this fall's midterm elections.

18 Oct 2018

FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices

As part of the Administration's ongoing efforts to strengthen cybersecurity in health care, the U.S. Food and Drug Administration and the U.S. Department of Homeland Security (DHS) announced a memorandum of agreement to implement a new framework for greater coordination and cooperation between the two agencies for addressing cybersecurity in medical devices.

17 Oct 2018

Video monitoring of TB therapy works well in urban and rural areas

Researchers from University of California San Diego School of Medicine, with statewide collaborators, report that patients who recorded videos of themselves taking tuberculosis medications better adhered to treatment than patients who were observed in-person.

16 Oct 2018

Medicare for all? CMS chief warns program has enough problems already

The Trump administration's top Medicare official Tuesday slammed the federal health program as riddled with problems that hinder care to beneficiaries, increase costs for taxpayers and escalate fraud and abuse.

16 Oct 2018

Improving access to behavioral health screenings for pregnant and postpartum women

The number one medical complication of pregnancy and childbirth for mothers is depression and/or anxiety, with one in seven women suffering from a mood disorder during pregnancy and the postpartum period.

16 Oct 2018

Trump administration, pharma exchange verbal volleys on drug-price transparency

The Trump administration and drugmakers are squaring off over a proposal to show drug prices in television ads.

16 Oct 2018

Video games could influence bystander attitudes and efficacy in situations of sexual assaults

As recent news headlines have shown, bystanders can play a pivotal role when it comes to sexual assault and relationship violence.

12 Oct 2018

A new vaccine shows promise in protecting people from rabies, Lassa fever

A novel vaccine designed to protect people from both Lassa fever and rabies showed promise in preclinical testing, according to new research published in Nature Communications.

12 Oct 2018

FDA approves novel molecular-based assay to help determine blood compatibility

The U.S. Food and Drug Administration today approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility.

11 Oct 2018

Good bacterium in probiotic digestive supplements helps eliminate Staphylococcus aureus

A new study from National Institutes of Health scientists and their Thai colleagues shows that a "good" bacterium commonly found in probiotic digestive supplements helps eliminate Staphylococcus aureus, a type of bacteria that can cause serious antibiotic-resistant infections.

11 Oct 2018

Discovery of gene mutation could offer benefit for people suffering from diabetes, heart disease, obesity

Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not.

10 Oct 2018

The feds’ termination of a tiny contract inflames bitter fight over fetal tissue

Federal health officials announced late last month they had terminated their contract with a company that supplies human fetal tissue for medical research and were checking that similar contracts, as well as studies conducted with that tissue, comply with federal law.

8 Oct 2018

Health insurers have inconsistent policy terms for non-drug pain treatments, study finds

Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating lower back pain, a study led by researchers at Johns Hopkins Bloomberg School of Public Health has found.

6 Oct 2018

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.

6 Oct 2018

Health and Human Services News and Research

FDA approves new antiviral flu treatment

Federal court orders Tennessee-based company to stop selling OTC drug products

Cocaine overdoses on the rise with fentanyl combo flooding the market

FDA targets 465 websites that sell potentially dangerous, unapproved drugs

Researchers identify common genetic connection in lung conditions

LU-RRTC to spearhead capacity-building efforts for racial and ethnic populations

Podcast: KHN’s ‘What the Health?’ Republicans’ preexisting political problem

FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices

Video monitoring of TB therapy works well in urban and rural areas

Medicare for all? CMS chief warns program has enough problems already

Improving access to behavioral health screenings for pregnant and postpartum women

Trump administration, pharma exchange verbal volleys on drug-price transparency

Video games could influence bystander attitudes and efficacy in situations of sexual assaults

A new vaccine shows promise in protecting people from rabies, Lassa fever

FDA approves novel molecular-based assay to help determine blood compatibility

Good bacterium in probiotic digestive supplements helps eliminate Staphylococcus aureus

Discovery of gene mutation could offer benefit for people suffering from diabetes, heart disease, obesity

The feds’ termination of a tiny contract inflames bitter fight over fetal tissue

Health insurers have inconsistent policy terms for non-drug pain treatments, study finds

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News